Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effect on hemodynamic changes in coronary artery bypass graft patients
IRCT20220316054311N1Phase 3Completed
- Sponsor
- Vice-Chancellery for Research, Hormozgan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in coronary arteriosclerosis, sponsored by Vice-Chancellery for Research, Hormozgan University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20220316054311N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220316054311N1.